Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-03-01
1997-07-08
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 520399, A61K 3830
Patent
active
056461160
ABSTRACT:
A composition for the treatment of osteoporosis and the method of treatment of osteoporosis therewith in mammals is disclosed. The method comprises administering Insulin-Like Growth Factor I (IGF-I) to a mammal in need thereof. Need is determined by bone mineral density levels, whether by single measurement (as compared to the population generally) or by a series of measurements evidencing a loss of bone mineral density, or due to a genetic or familial or other predisposition to bone mineral density loss.
REFERENCES:
Hock, Chem. Abst. 88, 14 (1988), abst. No. 50024e.
Stedman's Medical Dictionary, 24th ed., Williams & Wilkins, Baltimore, 1982, p. 1301.
Chiron Corporation Annual Report 1987 (1-page).
Journal of Bone and Mineral Res., vol. 6, Suppl 1 Abstr. 549 p. F-221, Aug. 1991.
Endocrinology, 123, No. 1 373-381 (1988).
J. Biological Chem. 263, No. 13, 6233-6239 May 5, 1988.
Biochem and Biophys. Res. Comm. 165, No. 2 766-771, 1989.
Proc. Natl. Acad. Sci., 83 4904-4907, 1986.
Biochem. and Biophys. Res. Comm. 149 No. 2 398-404, 1987.
Biochem. and Biophys. Res. Comm. 149 No. 2 pp. 672-679, 1987.
J. Biological Chemistry, 261, No. 13 5693-5695, May 5, 1986.
Proc. Natl. Acad. Sci. 85 4889-4893, Jul. 1988.
New England Journal of Medicine 318, 818-823 Mar. 31, 1988.
Pediatric Research 20, No. 9 825-827, 1986.
Endocrinology 116, No. 6 2563-2567, 1985.
Am. J. Physiol 250:E367-E372, 1986.
J. Clin Endocrinol and Metab, 701-704 1984.
Mayo Clin Proc. 60:827-835, 1985.
J. Clin. Invest 66, 709-719, Oct. 1980.
Metabolism 26 No. 10 Oct. 1977, 1079-1087.
J. Clin. Endocrinol. and Metab, 65 No. 4 697-702, 1987.
Annals of Internal Medicine, 1984 100:908-911.
Annals of Internal Medicine, 1986 104:874-876.
"Comparison of in vivo effects of insulin-like growth factors I and II and of growth harmone in hypophysectomized rats", Schoenle et al. ACTA Endocrinologica 1985-106-167-174 (Abstract).
"Insulin-Like Growth Factors Stimulate Synthesis of Nucleic Acids and Glycogen in Cutured Calvaria Cells", Schmid et al (Alcif Tissue Int. (1983) 35:578-585.
Johansson et al, The Lancet, vol. 339: Jun. 27, 1992 p. 1619. Insulin-Like Growth Factor I stimulates bone turnover in osteoporosis.
Ebling et al; Journal of Bone and Mineral Research, vol. 7, Supp. 1, Aug. 1992, Short-Term Effects of Recombinant Human Insulin-Like Growth Factor-I in Bone Turnover in Normal Women.
Schoenle et al, Comparison of in-vivo effects of Insulin-like Growth Factors I and II . . . , Acta Endocrinologica (1985) 106:167-114.
Schmid et al, Insulin-like Growth Factors Stimulate Synthesis of Nucleic Acids . . . , Calcif. Tissue Int. 35:578-585 (1983).
Mueller et al., Insulin-like Growth Factor-I increases Trabecalo Bone Mass in Ovariectomized Rat, J. Bone Mineral Res. vol. 6, Supp. 1, F-221, Abstract #549 (1991).
Bennett et al, Characterization of Insulin-like Growth Factor I Receptors on Cultured Rat Bone Cells: . . . , Endocrinology v. 115, No. 4, 1577-158 1984.
Schwander et al, Synthesis and Secretion of Insulin-like Growth Factor . . . , Endocrinology vol. 113, No. 1, 297-305 (1983).
Simpson, Growth Factors which affect Bone, Physiol. 235 TIBS Dec. 1984.
Hologic QDR.TM.-1000 Product Literature.
Annals of Internal Medicine 1984, v. 100, pp. 908-911 Radiologic Methods to Evaluate Bone Mineral Content.
Goffredsen et al, Total body bone mineral in vivo by dual photon absorptiometry, Clinical Physiology (1984) 4:343-355.
Wahner, Assessment of Metabolic Bone Disease Mayo Clin Proc 60:827-835, 1985.
Genant, et al, Osteoporosis:Assessment by Quantitative Computerized Tomography.
"Insulin-Like Growth Factor-1 Increases Trabecular Bone Mass in the Ovariectomized Rat". Mueller et al., J. Bone Mineral Res., Aug. 1991, vol. 6, Suppl. I Abstract 549 p. F-221.
Rote Liste, Editio Cantor, Aulendorf/Wurtt. 1988 Nos. 65-002-65-006-and 75,086.
Humbel, Rene E., (1990) "Insulin-Like Growth Factors I and II" Eur. J. Biochem. 190:445-462.
Merimee, Thomas J., (1987) "Insulin-Like Growth Factors in Pygmies" The New England Journal of Medicine 316(15):906-911.
Blackburn Robert P.
Ciba-Geigy AG
Collins Amy L.
Robins Roberta L.
Schain Howard E.
LandOfFree
Composition and method for the treatment of osteoporosis in mamm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for the treatment of osteoporosis in mamm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for the treatment of osteoporosis in mamm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2408866